Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
Jinoos Yazdany, Alfred H.J. Kim
Abstract
Two medications often used for treatment of immune-mediated conditions, hydroxychloroquine and chloroquine, have recently attracted widespread interest as potential therapies for coronavirus disease 2019. The authors of this commentary provide guidance for clinical decision making for patients with coronavirus disease 2019 as well as for patients with rheumatologic conditions, such as systemic lupus erythematosus and rheumatoid arthritis
Topics & Concepts
MedicineHydroxychloroquineAzithromycinChloroquinePandemicRandomized controlled trialRheumatoid arthritisIntensive care medicineClinical trialPharmacyInternal medicineCoronavirus disease 2019 (COVID-19)ImmunologyDiseaseMalariaFamily medicineAntibioticsInfectious disease (medical specialty)MicrobiologyBiologyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchDrug-Induced Ocular Toxicity